Authorised Prescriber Course
To provide health care practitioners with the knowledge they require to prescribe medicinal cannabis safely and effectively
Course Description
Our course is delivered online through a series of self paced modules designed by our expert ANZCCP founding members.
The course aims to equip doctors with the required knowledge to become cannabinoid authorised prescribers with the TGA and deliver a high level of care for their patients.
It covers cannabinoid medicine principles from basics to advanced with the latest cannabinoid research dissected and our first hand experience shared giving prescribing doctors a wide range of knowledge on the topic.
Enrolment is open to Australian and New Zealand registered doctors, nurses and pharmacists. Course enrolments also gain access to the members area including forums and grand rounds.
Successful completion will be one of the requirements under the ANZCCP HREC AP approval pathway.


Curriculum
Introduction
- The history of cannabis
- The cannabis plant
- The endocannabinoid system
- Phytocannabinoids
- terpenes
- whole plant medicine
Main indications
- CNCP
- Cancer pain and symptoms
- MS
- Insomnia
- Anxiety
- PTSD
- Epilepsy
Safety considerations
- Side effects and relative and absolute contraindications
- Drug interactions/ Safety
Prescribing – Practical Considerations
- Choosing a product / categories
- Dosing and titrations
Access pathways
- SAS B
- AP
- The AP approval - how to use it appropriately
What to expect
Upon completion of the education, participants will be able to:
- Understand and explain the anatomy, physiology, and pathophysiology of the human body’s endocannabinoid system.
- Understand and explain the constituents of cannabinoid base medications.
- Refer to latest studies and TGA guidelines to ensure best practice diagnosis, management and referral options for the treatment with cannabinoid-based medicines of CNCP, Cancer pain and symptoms, MS, insomnia, anxiety, PTSD, and epilepsy.
- Understand safety considerations in prescribing cannabinoid-based medications, including, side effects, relative and absolute contraindications, drug interactions and safety.
- Utilise best practice recommendations in medication selection, dosing, and titration for cannabinoid-based treatments.
- Select appropriate TGA prescribing pathways.
- Identify key health professionals to collaborate with in a multidisciplinary setting to support patients.
- Evaluate and communicate best practices for the daily administration of medicinal cannabis to patients.